SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

13 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 4148.20 millions, up 10.83% as compared to Rs. 3742.70 millions during the corresponding quarter last year.Handsome Net Profit growth of 57.59% reported above the corresponding previous quarter figure of Rs. 630.20 millions to Rs. 399.90 millions.OP of the company witnessed a marginal growth to 1130.20 millions from 768.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4148.20 3742.70 10.83 15021.30 15112.50 -0.60 15021.30 15112.50 -0.60
Other Income 56.80 0.00 0.00 110.10 12.80 760.16 110.10 12.80 760.16
PBIDT 1130.20 768.00 47.16 3571.60 3096.20 15.35 3571.60 3096.20 15.35
Interest 44.20 58.00 -23.79 166.30 204.90 -18.84 166.30 204.90 -18.84
PBDT 1086.00 710.00 52.96 3405.30 2891.30 17.78 3405.30 2891.30 17.78
Depreciation 173.20 142.50 21.54 660.10 557.70 18.36 660.10 557.70 18.36
PBT 912.80 567.50 60.85 2745.20 2333.60 17.64 2745.20 2333.60 17.64
TAX 282.60 167.60 68.62 738.70 616.30 19.86 738.70 616.30 19.86
Deferred Tax 165.60 27.60 500.00 278.10 95.00 192.74 278.10 95.00 192.74
PAT 630.20 399.90 57.59 2006.50 1717.30 16.84 2006.50 1717.30 16.84
Equity 453.10 453.10 0.00 453.10 453.10 0.00 453.10 453.10 0.00
PBIDTM(%) 27.25 20.52 32.78 23.78 20.49 16.05 23.78 20.49 16.05

Aarti Pharmalabs Share Price

699.45 -3.10 (-0.44%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×